Active and passive Abeta-immunotherapy: preclinical and clinical studies and future directions: part I.
Agadjanyan
Michael G
MG
Cribbs
David H
DH
D000544:Alzheimer Disease / Q000276:immunology / Q000378:metabolism / Q000628:therapy*; D016229:Amyloid beta-Peptides / Q000276:immunology* / Q000378:metabolism; D000818:Animals; D004195:Disease Models, Animal; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D051379:Mice
D016229:Amyloid beta-Peptides